Future Market Insights has announced the addition of the “Endometrial Cancer Treatment Market: Global Industry Analysis and Opportunity Assessment 2017-2027" report to their offering.

1. Endometrial Cancer Treatment Market
March 2017
©2015 Future Market Insights, All Rights Reserved
Report Id : REP-GB-2834
Status : Ongoing
Category : Healthcare, Pharmaceuticals & Medical Devices

2. About
Future Market Insights
©2015 Future Market Insights, All Rights Reserved
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom
research reports, and consulting services. We deliver a complete packaged solution, which
combines current market intelligence, statistical anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC,
ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy,
Technology, Healthcare, and Retail.
We have a global presence with delivery centers across India specializing in providing global
research reports and country research reports. FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning
from every corner of the world to distill it to one thing – the perfect solution for our client.
Research Capabilities
Subscription Information
 Customized Research
 Syndicated Research
 Investment Research
 Social Media Research
Sector Coverage
 Automotive and Transportation
 Electronics, Semiconductor, and ICT
 Retail and Consumer Products
 Industrial Automation and Equipment
 Chemicals & Materials
 Food and Beverages
 Services and Utilities
 Energy, Mining, Oil, and Gas
For detailed subscription information please contact
Hari. T (Sr. Manager - Global Business Development)
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Email: hari.t@futuremarketinsights.com
Customized
Research
Syndicated
Research
Investment
Research
Social Media
Research
2

3. Research Methodology (1/2)
Systematic Research Approach
In-depth secondary research is used to
ascertain overall market size, top
industry players, top products, industry
associations, etc.
PMR formulates a detailed discussion
guide to conduct expert and industry
interviews
PMR develops a list of industry players
(manufacturers), distributors, retailers
and industry experts
PMR conducts interviews with industry
experts, industry players, distributors
and retailers
Data is validated by triangulation
method, wherein secondary, primary
and PMR analysis contribute to the final
data
Data is scrutinized using MS-Excel to
obtain qualitative and quantitative
insights about the industry
PMR delivers industry insights and
information in the required format
(PDF)
Data
Collection
Data Filter
& Analysis
Research &
Intelligence
Actionable
Insights
Business
Solution
A
C
B
Primary
Research
Company
Analysis
Desk
Research
 Identifying key opinion leaders
 Questionnaire design
 In-depth interviews
 Coverage across value chain
 Market participants
 Key strengths
 Product portfolio
 Mapping as per value chain
 Key focus segments
 Key industry experts
 Channel study
 Developments
 Market dynamics
 Products
 Conclusions
SOLUTION
Primary Research#
 Linkedin
 Zoominfo
 Salesforce
 Avention
 Factiva
 GBI
 Genios
 Meltwater
 Company websites
 Company annual
reports
 White papers
 Financial reports
©2015 Future Market Insights, All Rights Reserved
Secondary Research # Paid Publications#
Insights
Market profiling
Formulating discussion guide
Developing list of respondents
Data analysis
Data validation
Data collection
1
2
3
4
5
6
7
# includes sources of databases
3

4. Endometrial cancer or uterine cancer is one of the most common gynecological cancers and 2.8% of
women are diagnosed with the endometrial cancer at some point in their lives. According to National
Cancer Institute statistics, in 2015 endometrial cancer contributed to 1.8% of all cancers and 3.6% of all
new cancer cases were diagnosed as endometrial cancer. Early detection of endometrial cancer helps in
the selection of proper treatment options. Endometrial cancers are typically diagnosed as type I and type
II tumors and majority of the patients diagnosed with endometrial cancer represent early-stage cancers.
According to Yale University School of Medicine, U.S., in 2014, type I tumors constitute 80% of all cases of
endometrial cancers diagnosed in the U.S. Endometrial cancer can be treated by one or combination of
chemotherapy, radiation therapy and hormone therapy. Most of the physicians recommend combination
treatments as chemotherapy alone has traditionally been deem ineffective. Adjuvant radiation therapy is
preferred in patients who have diagnosed with sage I or II endometrial cancer. Radiation therapy is also
recommended in patients who have undergone the surgery, in order to avoid the relapse of endometrial
cancer. Endometrial cancer is often detected in women above the age of 50 years and risk of endometrial
cancer increases with the age. Also the risk of development of endometrial cancer is more in breast
cancer patients who are being treated with tamoxifen or estrogen for long time. Plenty of
chemotherapeutic agents are available and are recommended in the combination for the treatment of
endometrial cancer. Some of the combination therapies include carboplatin & paclitaxel, Cisplatin &
doxorubicin, Carboplatin & docetaxel and others.
Endometrial Cancer Treatment Market: Drivers and Restraints
Increasing incidence of uterine serous carcinoma – a highly aggressive variant of endometrial cancer –
and relapse of endometrial cancers in patients treated with chemotherapy are the prime factors driving
the growth of global endometrial cancer treatment market over the forecast period. In 2014, uterine
serous carcinoma represented 10% of all caseload of endometrial cancers in the U.S.
Endometrial Cancer Treatment Market Analysis
©2015 Future Market Insights, All Rights Reserved 4

5. Some of the risk factors of endometrial cancer include obesity, presence of polycystic ovarian syndrome,
long-term consumption of birth control pills, delayed pregnancy etc. Increasing incidence of obesity in
the women aged above 50 can lead to the growth of endometrial cancer treatment market. However,
divergent nature of cancer and increasing stringency in the regulatory requirements are the prime factors
limiting the growth of global endometrial cancer treatment market. Besides this, side effects related to
chemotherapy, radiation therapy and hormone therapy also restricts the adoption of these agents for
endometrial cancer treatment.
Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-2834
Endometrial Cancer Treatment Market: Segmentation
The global endometrial cancer treatment market has been segmented on the basis of treatment type,
end user, and geography.
Based on treatment type, the global endometrial cancer treatment market is divided into following:
 Chemotherapy
 Carboplatin
 Paclitaxel
Endometrial Cancer Treatment Market Analysis
©2015 Future Market Insights, All Rights Reserved 5

6.  Ixabepilone
 Others
 Hormonal Therapy
 Megestrol (Megace)
 Medroxyprogesterone (PROVERA)
 Others (anastrozole, letrozole, etc.)
 Radiation Therapy
 Whole Pelvic External-beam Radiation Therapy
 Vaginal Brachytherapy
 Surgery
 Hysterectomy
 Bilateral Salpingo-oophorectomy (removal of both fallopian tubes and ovaries)
Endometrial Cancer Treatment Market Analysis
©2015 Future Market Insights, All Rights Reserved 6

7. Based on end user, the global endometrial cancer treatment market is segmented as below:
 Retail Pharmacy
 Hospital pharmacy
 Clinics
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-2834
Endometrial Cancer Treatment Market: Overview
Global market for endometrial cancer treatment is forecast to grow at moderate rate owing to less
number of drugs approved for treatment of endometrial cancer. Despite of this, chemotherapy segment
is expected to hold the highest share in the global endometrial cancer treatment market due to high
adoption rate of chemotherapy over radiation and surgical treatment. Also chemotherapeutic agents
such as carboplatin and paclitaxel are recommended as a first line of therapy in majority of the cases,
which increases demand for these products. Recent FDA approval of IXEMPRA (ixabepilone) for use in the
treatment of endometrial cancer treatment is expected to fuel the growth of global market over the
forecast period.
Endometrial Cancer Treatment Market Analysis
©2015 Future Market Insights, All Rights Reserved 7

8. Endometrial Cancer Treatment Market: Regional Wise Outlook
Geographically, the global endometrial cancer treatment market is classified into regions viz. North
America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa.
North America will continue to hold largest share in the global endometrial cancer treatment market due
to high incidence of uterine serous carcinoma. Europe is expected to hold the second largest share in the
global market partly due to increasing product availability in the region. North America is expected to
expand at the highest rate over the forecast period.
Full Report Analysis@ http://www.futuremarketinsights.com/reports/endometrial-cancer-treatment-
market
Endometrial Cancer Treatment Market: Key Players
Some of the players operating in the global endometrial cancer treatment market include R-Pharm-US
LLC., Bristol-Myers Squibb Company, Pfizer Inc., AstraZeneca Plc., Novartis AG and others. The global
endometrial cancer treatment market is expected to grow in future due to increasing investment by
multinational companies in cancer research.
Endometrial Cancer Treatment Market Analysis
©2015 Future Market Insights, All Rights Reserved 8

9. ©2015 Future Market Insights, All Rights Reserved
Future Market Insights Global & Consulting Private Limited (FMI)
Thank You
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
sales@futuremarketinsights.com
For media queries, contact the press office at
press@futuremarketinsights.com
For other queries contact:
Harish Tiwari
(General Manager & Global Head Business Development)
Future Market Insights: 3rd Floor,
207 Regent Street, London W1B 3HH
T: +44 20 7692 8790 | D: +44 20 3287 4268
Email: hari.t@futuremarketinsights.com
9